Tranexamic Acid Versus Blood Stopper Treatments in Epistaxis Management

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorAnkara Ataturk Sanatorium Training and Research Hospital

About this trial

In this randonmized controlled trial, aim to compare the effectiveness of local administration of tranexamic acid and blood stopper (Ankaferd®) on cessation of bleeding in epistaxis patients.

Eligibility criteria

Qualifiers

Patients over 18 years of age with epistaxis will present to the emergency department with non-traumatic epistaxis and whose bleeding do not stop with simple external compression for 10 minutes.

Disqualifiers

Patients demonstrating hemodynamic instability

Patients with documented allergy to tranexamic acid or Ankaferd

patients with known bleeding disorders,

patients using anticoagulants,

Trial design

Treatments tested in this trial

  • Blood Stopper (Ankaferd)

Treatment groups

186 Participants
are divided into 2 treatment groups

Locations

This trial has no locations